Pneumonia, COVID-19 and influenza are continuous threats to our lung health and overall health. Those living with lung disease are at even greater risk of developing serious outcomes such as hospitalization and death from these infectious respiratory diseases. The good news is the risk of infection and severe outcomes can be reduced.

Join Dr. Alyson Kelvin, Virologist and Vaccinologist to learn about these cutting edge vaccinations and why prevention is good medicine. 

About Dr. Alyson Kelvin

Dr. Alyson Kelvin, PhD is an early career virologist and vaccinologist at the Vaccine and Infectious Disease Organization. Her research focuses on emerging respiratory viruses of pandemic potential to develop broadly protective vaccines and understand disease mechanisms such as Long COVID. In 2003, Dr. Kelvin was part of a team investigating SARS-CoV infection in patients in Toronto. She has since studied many high-profile viruses including H7N9, pandemic H1N1, historical influenza viruses, Zika virus, and SARS-CoV-2. Dr. Kelvin responded immediately after the identification of SARS-CoV-2 initiating studies in January 2020 for COVID-19 vaccine development in Canada. This work is documented in the Nature of Things episode The Great Vaccine Race. She is a member of the World Health Organization’s working groups COVID19 Vaccine Development and COVID-19 Assays and has spoken frequently with Canadian parliament and Senate regarding COVID-19.